{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:01:50Z","timestamp":1776276110356,"version":"3.50.1"},"reference-count":228,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10787-024-01593-x","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T18:07:05Z","timestamp":1730570825000},"page":"49-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Gut microbiome and inflammation in cardiovascular drug response: trends in therapeutic success and commercial focus"],"prefix":"10.1007","volume":"33","author":[{"given":"Firoz","family":"Anwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad A.","family":"Al-Abbasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar A.","family":"Al-Bar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amita","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9984-0437","authenticated-orcid":false,"given":"Vikas","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"issue":"8","key":"1593_CR1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1021\/acschembio.1c00192","volume":"16","author":"AA Adhikari","year":"2021","unstructured":"Adhikari AA et al (2021) A gut-restricted lithocholic acid analog as an inhibitor of gut bacterial bile salt hydrolases. ACS Chem Biol 16(8):1401\u20131412","journal-title":"ACS Chem Biol"},{"key":"1593_CR2","first-page":"1","volume-title":"Gut microbiome, microbial metabolites and cardiometabolic risk","author":"S Aiyer","year":"2023","unstructured":"Aiyer S, Tang WW (2023) Gut microbial metabolism in heart failure. Gut microbiome, microbial metabolites and cardiometabolic risk. Springer, Cham, pp 1\u201322"},{"issue":"1","key":"1593_CR3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s11033-024-09398-5","volume":"51","author":"OM Al-Fakhrany","year":"2024","unstructured":"Al-Fakhrany OM, Elekhnawy E (2024) Next-generation probiotics: the upcoming biotherapeutics. Mol Biol Rep 51(1):505","journal-title":"Mol Biol Rep"},{"issue":"6","key":"1593_CR4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1476-5381.2012.02081.x","volume":"167","author":"KM Ali","year":"2012","unstructured":"Ali KM et al (2012) Cardiovascular disease risk reduction by raising HDL cholesterol\u2013current therapies and future opportunities. Br J Pharmacol 167(6):1177\u20131194","journal-title":"Br J Pharmacol"},{"issue":"6","key":"1593_CR5","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.3390\/microorganisms12061138","volume":"12","author":"J \u00c1lvarez-Herms","year":"2024","unstructured":"\u00c1lvarez-Herms J (2024) Summatory effects of anaerobic exercise and a \u2018westernized athletic diet\u2019on gut dysbiosis and chronic low-grade metabolic acidosis. Microorganisms 12(6):1138","journal-title":"Microorganisms"},{"issue":"1","key":"1593_CR6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.atherosclerosis.2014.08.045","volume":"237","author":"R Anderson","year":"2014","unstructured":"Anderson R, Bundhoo S, James P (2014) A new mechanism of action of thienopyridine antiplatelet drugs\u2013a role for gastric nitrosthiol metabolism? Atherosclerosis 237(1):369\u2013373","journal-title":"Atherosclerosis"},{"key":"1593_CR7","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.4c00022","author":"BG Anderson","year":"2024","unstructured":"Anderson BG et al (2024) Offline two-dimensional liquid chromatography-mass spectrometry for deep annotation of the fecal metabolome following fecal microbiota transplantation. J Proteome Res. https:\/\/doi.org\/10.1021\/acs.jproteome.4c00022","journal-title":"J Proteome Res"},{"issue":"4","key":"1593_CR8","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22986","volume":"36","author":"F Anwar","year":"2022","unstructured":"Anwar F et al (2022) Pharmacological role of Vitamin C in stress-induced cardiac dysfunction via alteration in Gut microbiota. J Biochem Mol Toxicol 36(4):e22986","journal-title":"J Biochem Mol Toxicol"},{"issue":"1","key":"1593_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2023.12.009","volume":"57","author":"M Arifuzzaman","year":"2024","unstructured":"Arifuzzaman M et al (2024) Nutritional regulation of microbiota-derived metabolites: Implications for immunity and inflammation. Immunity 57(1):14\u201327","journal-title":"Immunity"},{"issue":"3","key":"1593_CR10","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/microbiolres15030106","volume":"15","author":"N Asai","year":"2024","unstructured":"Asai N et al (2024) COPD pathogenesis and alterations in the oral, lung, and gut microbiomes. Microbiol Res 15(3):1605\u20131615","journal-title":"Microbiol Res"},{"key":"1593_CR11","volume":"178","author":"TO Asar","year":"2024","unstructured":"Asar TO et al (2024) Metformin\u2019s dual impact on Gut microbiota and cardiovascular health: a comprehensive analysis. Biomed Pharmacother 178:117128","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1593_CR12","first-page":"53","volume":"14","author":"F Atarbashi-Moghadam","year":"2018","unstructured":"Atarbashi-Moghadam F et al (2018) Periopathogens in atherosclerotic plaques of patients with both cardiovascular disease and chronic periodontitis. ARYA Atheroscler 14(2):53","journal-title":"ARYA Atheroscler"},{"key":"1593_CR13","doi-asserted-by":"crossref","first-page":"464656","DOI":"10.1016\/j.chroma.2024.464656","volume":"1717","author":"M Bajo-Fern\u00e1ndez","year":"2024","unstructured":"Bajo-Fern\u00e1ndez M et al (2024) Structural elucidation of derivatives of polyfunctional metabolites after methyl chloroformate derivatization by high-resolution mass spectrometry gas chromatography. Application to microbiota metabolites. J Chromatogr A 1717:464656","journal-title":"J Chromatogr A"},{"issue":"2","key":"1593_CR14","volume":"3","author":"V Bidault-Jourdainne","year":"2021","unstructured":"Bidault-Jourdainne V et al (2021) TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload. JHEP Rep 3(2):100214","journal-title":"JHEP Rep"},{"issue":"1","key":"1593_CR15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/ibd\/izad126","volume":"30","author":"A Blesl","year":"2024","unstructured":"Blesl A et al (2024) Prediction of response to systemic corticosteroids in active UC by microbial composition\u2014a prospective multicenter study. Inflamm Bowel Dis 30(1):9\u201319","journal-title":"Inflamm Bowel Dis"},{"key":"1593_CR16","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000533","author":"G Borgiani","year":"2024","unstructured":"Borgiani G et al (2024) The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response? Int Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/YIC.0000000000000533","journal-title":"Int Clin Psychopharmacol"},{"issue":"1","key":"1593_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40246-020-00260-w","volume":"14","author":"CN Brocker","year":"2020","unstructured":"Brocker CN et al (2020) Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites. Hum Genomics 14(1):1\u20139","journal-title":"Hum Genomics"},{"key":"1593_CR18","first-page":"e5dd1964","volume":"18","author":"SJ Bunu","year":"2024","unstructured":"Bunu SJ, Kela S, Eke BU (2024) Titrimetric and thin layer chromatographic fingerprint analysis of captopril solid dosage form\u2013an angiotensin-converting enzyme inhibitor. Drug Discov 18:e5dd1964","journal-title":"Drug Discov"},{"key":"1593_CR19","first-page":"2137","volume-title":"Clinical trial evidence of the gut microbial metabolite butyrate in hypertension","author":"L Camargo Tavares","year":"2024","unstructured":"Camargo Tavares L, Marques FZ (2024) Clinical trial evidence of the gut microbial metabolite butyrate in hypertension. Lippincott Williams & Wilkins Hagerstown, Hagerstown, pp 2137\u20132139"},{"issue":"7","key":"1593_CR20","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1093\/gerona\/glz222","volume":"75","author":"CS Carter","year":"2020","unstructured":"Carter CS et al (2020) Therapeutic delivery of Ang (1\u20137) via genetically modified probiotic: a dosing study. J Gerontol Ser A 75(7):1299\u20131303","journal-title":"J Gerontol Ser A"},{"key":"1593_CR21","first-page":"3110","volume":"8","author":"H-Q Chen","year":"2021","unstructured":"Chen H-Q et al (2021) Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment. Front Med 8:3110","journal-title":"Front Med"},{"key":"1593_CR22","volume":"8","author":"H-Q Chen","year":"2022","unstructured":"Chen H-Q et al (2022a) Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment. Front Med 8:742394","journal-title":"Front Med"},{"issue":"9","key":"1593_CR23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/dmd.122.000906","volume":"50","author":"X Chen","year":"2022","unstructured":"Chen X et al (2022b) Antibiotics-induced disruption of gut microbiota increases systemic exposure of clopidogrel active metabolite in type 2 diabetic rats. Drug Metab Dispos 50(9):1142\u20131150","journal-title":"Drug Metab Dispos"},{"issue":"1\u20133","key":"1593_CR24","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1089\/ars.2021.0115","volume":"38","author":"C-Y Chen","year":"2023","unstructured":"Chen C-Y et al (2023) Inhibition of trimethylamine N-oxide attenuates neointimal formation through reduction of inflammasome and oxidative stress in a mouse model of carotid artery ligation. Antioxid Redox Signal 38(1\u20133):215\u2013233","journal-title":"Antioxid Redox Signal"},{"key":"1593_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.08.002","author":"X Chen","year":"2024","unstructured":"Chen X, Gu J, Zhang X (2024a) Brain-heart axis and the inflammatory response: connecting stroke and cardiac dysfunction. Cardiology. https:\/\/doi.org\/10.1016\/j.ekir.2024.08.002","journal-title":"Cardiology"},{"issue":"7","key":"1593_CR26","volume":"12","author":"L Chen","year":"2024","unstructured":"Chen L et al (2024b) Interactions between toll-like receptors signaling pathway and gut microbiota in host homeostasis. Immunity, Inflammation and Disease 12(7):e1356","journal-title":"Immunity, Inflammation and Disease"},{"key":"1593_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797062","author":"T Cheng","year":"2021","unstructured":"Cheng T et al (2021) The intestinal effect of atorvastatin: Akkermansia muciniphila and barrier function. Front Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.797062","journal-title":"Front Microbiol"},{"issue":"1","key":"1593_CR28","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1038\/s41598-023-50891-x","volume":"14","author":"A Chopra","year":"2024","unstructured":"Chopra A et al (2024) Exploring the presence of oral bacteria in non-oral sites of patients with cardiovascular diseases using whole metagenomic data. Sci Rep 14(1):1476","journal-title":"Sci Rep"},{"issue":"28","key":"1593_CR29","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.3748\/wjg.v29.i28.4368","volume":"29","author":"M Colella","year":"2023","unstructured":"Colella M et al (2023) Microbiota revolution: How gut microbes regulate our lives. World J Gastroenterol 29(28):4368","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1593_CR30","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3390\/biomedicines11020431","volume":"11","author":"LA Constantino-Jonapa","year":"2023","unstructured":"Constantino-Jonapa LA et al (2023) Contribution of trimethylamine N-oxide (TMAO) to chronic inflammatory and degenerative diseases. Biomedicines 11(2):431","journal-title":"Biomedicines"},{"issue":"2","key":"1593_CR31","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.coph.2013.01.008","volume":"13","author":"RM Cooper-DeHoff","year":"2013","unstructured":"Cooper-DeHoff RM, Chang S-W, Pepine CJ (2013) Calcium antagonists in the treatment of coronary artery disease. Curr Opin Pharmacol 13(2):301\u2013308","journal-title":"Curr Opin Pharmacol"},{"key":"1593_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.08.038","author":"EJ Culp","year":"2024","unstructured":"Culp EJ et al (2024) Microbial transformation of dietary xenobiotics shapes gut microbiome composition. Cell. https:\/\/doi.org\/10.1016\/j.cell.2024.08.038","journal-title":"Cell"},{"issue":"1","key":"1593_CR33","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s11033-024-09437-1","volume":"51","author":"L da Cunha Agostini","year":"2024","unstructured":"da Cunha Agostini L et al (2024) Single nucleotide polymorphism (SNP) rs4291 of the angiotensin-converting enzyme (ACE) gene is associated with the response to losartan treatment in hypertensive patients. Mol Biol Rep 51(1):458","journal-title":"Mol Biol Rep"},{"issue":"1","key":"1593_CR34","doi-asserted-by":"crossref","first-page":"H83","DOI":"10.1530\/VB-19-0023","volume":"1","author":"C Dal Lin","year":"2019","unstructured":"Dal Lin C, Tona F, Osto E (2019) The crosstalk between the cardiovascular and the immune system. Vasc Biol 1(1):H83\u2013H88","journal-title":"Vasc Biol"},{"issue":"1","key":"1593_CR35","doi-asserted-by":"crossref","first-page":"2369337","DOI":"10.1080\/19490976.2024.2369337","volume":"16","author":"T Dapa","year":"2024","unstructured":"Dapa T, Xavier KB (2024) Effect of diet on the evolution of gut commensal bacteria. Gut Microbes 16(1):2369337","journal-title":"Gut Microbes"},{"issue":"18","key":"1593_CR36","doi-asserted-by":"crossref","first-page":"10208","DOI":"10.3390\/ijms251810208","volume":"25","author":"S Datta","year":"2024","unstructured":"Datta S et al (2024) Role of gut microbial metabolites in cardiovascular diseases\u2014current insights and the road ahead. Int J Mol Sci 25(18):10208","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1593_CR37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu11010051","volume":"11","author":"J De la Cuesta-Zuluaga","year":"2018","unstructured":"De la Cuesta-Zuluaga J et al (2018) Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients 11(1):51","journal-title":"Nutrients"},{"key":"1593_CR38","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ebiom.2019.05.063","volume":"44","author":"HC Descamps","year":"2019","unstructured":"Descamps HC et al (2019) The path toward using microbial metabolites as therapies. EBioMedicine 44:747\u2013754","journal-title":"EBioMedicine"},{"issue":"2","key":"1593_CR39","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F et al (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19(2):275\u2013293","journal-title":"Intern Emerg Med"},{"issue":"12","key":"1593_CR40","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.1021\/acs.jafc.3c08363","volume":"72","author":"Y Di","year":"2024","unstructured":"Di Y et al (2024) Chicoric acid alleviates colitis via targeting the gut microbiota accompanied by maintaining intestinal barrier integrity and inhibiting inflammatory responses. J Agric Food Chem 72(12):6276\u20136288","journal-title":"J Agric Food Chem"},{"issue":"6","key":"1593_CR41","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202101986R","volume":"36","author":"IJ Dikeocha","year":"2022","unstructured":"Dikeocha IJ et al (2022) Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. FASEB J 36(6):e22350","journal-title":"FASEB J"},{"issue":"2","key":"1593_CR42","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1039\/D3FO04396G","volume":"15","author":"H Ding","year":"2024","unstructured":"Ding H et al (2024) Protocatechuic acid alleviates TMAO-aggravated atherosclerosis via mitigating inflammation, regulating lipid metabolism, and reshaping gut microbiota. Food Funct 15(2):881\u2013893","journal-title":"Food Funct"},{"key":"1593_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-024-05077-y","author":"G Ding","year":"2024","unstructured":"Ding G et al (2024) Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases. Mol Cell Biochem. https:\/\/doi.org\/10.1007\/s11010-024-05077-y","journal-title":"Mol Cell Biochem"},{"issue":"5","key":"1593_CR44","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13238-018-0547-2","volume":"9","author":"M Doestzada","year":"2018","unstructured":"Doestzada M et al (2018) Pharmacomicrobiomics: a novel route towards personalized medicine? Protein Cell 9(5):432\u2013445","journal-title":"Protein Cell"},{"issue":"2","key":"1593_CR45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.3390\/molecules28020612","volume":"28","author":"S Dong","year":"2023","unstructured":"Dong S et al (2023) Effects of losartan, atorvastatin, and aspirin on blood pressure and gut microbiota in spontaneously hypertensive rats. Molecules 28(2):612","journal-title":"Molecules"},{"key":"1593_CR46","doi-asserted-by":"crossref","first-page":"1249644","DOI":"10.3389\/fphar.2023.1249644","volume":"14","author":"X Du","year":"2023","unstructured":"Du X et al (2023) Pharmacological intervention of curcumin via the NLRP3 inflammasome in ischemic stroke. Front Pharmacol 14:1249644","journal-title":"Front Pharmacol"},{"issue":"13","key":"1593_CR47","doi-asserted-by":"crossref","first-page":"7379","DOI":"10.3390\/ijms25137379","volume":"25","author":"Y Du","year":"2024","unstructured":"Du Y et al (2024) The role of short chain fatty acids in inflammation and body health. Int J Mol Sci 25(13):7379","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"1593_CR48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1080\/03602532.2023.2186313","volume":"55","author":"A D\u017eidi\u0107-Krivi\u0107","year":"2023","unstructured":"D\u017eidi\u0107-Krivi\u0107 A et al (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metab Rev 55(1\u20132):126\u2013139","journal-title":"Drug Metab Rev"},{"issue":"1","key":"1593_CR49","doi-asserted-by":"crossref","first-page":"1887721","DOI":"10.1080\/19490976.2021.1887721","volume":"13","author":"JL Ellis","year":"2021","unstructured":"Ellis JL et al (2021) Dietary vitamin K is remodeled by gut microbiota and influences community composition. Gut Microbes 13(1):1887721","journal-title":"Gut Microbes"},{"key":"1593_CR50","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.csbj.2020.12.008","volume":"19","author":"AC Engevik","year":"2021","unstructured":"Engevik AC, Engevik MA (2021) Exploring the impact of intestinal ion transport on the gut microbiota. Comput Struct Biotechnol J 19:134\u2013144","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"1593_CR51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13063-021-05959-2","volume":"23","author":"L Fan","year":"2022","unstructured":"Fan L et al (2022) Effect of fecal microbiota transplantation on primary hypertension and the underlying mechanism of gut microbiome restoration: protocol of a randomized, blinded, placebo-controlled study. Trials 23(1):1\u201314","journal-title":"Trials"},{"key":"1593_CR52","doi-asserted-by":"crossref","first-page":"1147687","DOI":"10.3389\/fcimb.2023.1147687","volume":"13","author":"H Fan","year":"2023","unstructured":"Fan H et al (2023) Gut microbiota and cardiac arrhythmia. Front Cell Infect Microbiol 13:1147687","journal-title":"Front Cell Infect Microbiol"},{"key":"1593_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2024.08.002","author":"Y Fang","year":"2024","unstructured":"Fang Y et al (2024) Role of bile acid receptors in the development and function of diabetic nephropathy. Kidney Int Rep. https:\/\/doi.org\/10.1016\/j.ekir.2024.08.002","journal-title":"Kidney Int Rep"},{"issue":"5","key":"1593_CR54","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/febs.15486","volume":"288","author":"C Farrugia","year":"2021","unstructured":"Farrugia C et al (2021) Mechanisms of vascular damage by systemic dissemination of the oral pathogen Porphyromonas gingivalis. FEBS J 288(5):1479\u20131495","journal-title":"FEBS J"},{"issue":"24","key":"1593_CR55","doi-asserted-by":"crossref","first-page":"11278","DOI":"10.7150\/thno.47289","volume":"10","author":"W Feng","year":"2020","unstructured":"Feng W et al (2020) Targeting gut microbiota for precision medicine: focusing on the efficacy and toxicity of drugs. Theranostics 10(24):11278","journal-title":"Theranostics"},{"key":"1593_CR56","doi-asserted-by":"crossref","first-page":"101291","DOI":"10.1016\/j.plipres.2024.101291","volume":"95","author":"S Fiorucci","year":"2024","unstructured":"Fiorucci S et al (2024) Immunology of bile acids regulated receptors. Prog Lipid Res 95:101291","journal-title":"Prog Lipid Res"},{"issue":"12","key":"1593_CR57","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1001\/jamacardio.2021.3490","volume":"6","author":"PM Freaney","year":"2021","unstructured":"Freaney PM et al (2021) Premature menopause and 10-year risk prediction of atherosclerotic cardiovascular disease. JAMA Cardiol 6(12):1463\u20131465","journal-title":"JAMA Cardiol"},{"issue":"12","key":"1593_CR58","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","volume":"25","author":"D Furman","year":"2019","unstructured":"Furman D et al (2019) Chronic inflammation in the etiology of disease across the life span. Nat Med 25(12):1822\u20131832","journal-title":"Nat Med"},{"issue":"1","key":"1593_CR59","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge X et al (2020) The gut microbial metabolite trimethylamine N-oxide and hypertension risk: a systematic review and dose\u2013response meta-analysis. Adv Nutr 11(1):66\u201376","journal-title":"Adv Nutr"},{"issue":"12","key":"1593_CR60","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/diagnostics14121234","volume":"14","author":"D Georgescu","year":"2024","unstructured":"Georgescu D et al (2024) Cholesterol gallstones and long-term use of statins: is gut microbiota dysbiosis bridging over uncertainties? Diagnostics 14(12):1234","journal-title":"Diagnostics"},{"issue":"19","key":"1593_CR61","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.3390\/ijms251910255","volume":"25","author":"P Guevara-Ram\u00edrez","year":"2024","unstructured":"Guevara-Ram\u00edrez P et al (2024) Gut microbiota disruption in hematologic cancer Therapy: molecular insights and implications for treatment efficacy. Int J Mol Sci 25(19):10255","journal-title":"Int J Mol Sci"},{"key":"1593_CR62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","volume":"51","author":"M Gurung","year":"2020","unstructured":"Gurung M et al (2020) Role of gut microbiota in type 2 diabetes pathophysiology. EBioMedicine 51:102590","journal-title":"EBioMedicine"},{"issue":"6143","key":"1593_CR63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1126\/science.1235872","volume":"341","author":"HJ Haiser","year":"2013","unstructured":"Haiser HJ et al (2013) Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 341(6143):295\u2013298","journal-title":"Science"},{"issue":"2","key":"1593_CR64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/gmic.27915","volume":"5","author":"HJ Haiser","year":"2014","unstructured":"Haiser HJ et al (2014) Mechanistic insight into digoxin inactivation by Eggerthella lenta augments our understanding of its pharmacokinetics. Gut Microbes 5(2):233\u2013238","journal-title":"Gut Microbes"},{"issue":"6","key":"1593_CR65","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.addr.2007.04.005","volume":"59","author":"A Hanafy","year":"2007","unstructured":"Hanafy A et al (2007) Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug. Adv Drug Deliv Rev 59(6):419\u2013426","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"1593_CR66","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/s12967-024-04974-6","volume":"22","author":"M He","year":"2024","unstructured":"He M et al (2024a) Gut microbial metabolites SCFAs and chronic kidney disease. J Transl Med 22(1):172","journal-title":"J Transl Med"},{"key":"1593_CR67","doi-asserted-by":"crossref","first-page":"1392249","DOI":"10.3389\/fcimb.2024.1392249","volume":"14","author":"J He","year":"2024","unstructured":"He J et al (2024b) Gut microbiome-derived hydrolases\u2014an underrated target of natural product metabolism. Front Cell Infect Microbiol 14:1392249","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"1593_CR68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s12265-022-10330-0","volume":"16","author":"Y Huang","year":"2023","unstructured":"Huang Y et al (2023) The role of gut microbiota and trimethylamine N-oxide in cardiovascular diseases. J Cardiovasc Transl Res 16(3):581\u2013589","journal-title":"J Cardiovasc Transl Res"},{"key":"1593_CR69","doi-asserted-by":"crossref","first-page":"102428","DOI":"10.1016\/j.eclinm.2024.102428","volume":"68","author":"H Huang","year":"2024","unstructured":"Huang H et al (2024) Exposure to prescribed medication in early life and impacts on gut microbiota and disease development. EClinicalMedicine 68:102428","journal-title":"EClinicalMedicine"},{"issue":"7","key":"1593_CR70","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4103\/1673-5374.385846","volume":"19","author":"Q Huang","year":"2024","unstructured":"Huang Q et al (2024) Hemorrhagic transformation in patients with large-artery atherosclerotic stroke is associated with the gut microbiota and lipopolysaccharide. Neural Regen Res 19(7):1532\u20131540","journal-title":"Neural Regen Res"},{"key":"1593_CR71","unstructured":"Huli\u010diak M (2024) Study of intestinal transporters and their role in drug absorption. Dizerta\u010dn\u00ed pr\u00e1ce, vedouc\u00ed \u010cerven\u00fd, Luk\u00e1\u0161. Hradec Kr\u00e1lov\u00e9: Univerzita Karlova, Farmaceutick\u00e1 fakulta v Hradci Kr\u00e1lov\u00e9, Katedra farmakologie a toxikologie"},{"key":"1593_CR72","doi-asserted-by":"crossref","first-page":"dxae019","DOI":"10.1093\/intimm\/dxae019","volume":"36","author":"K Iwabuchi","year":"2024","unstructured":"Iwabuchi K et al (2024) Recent advances regarding the potential roles of invariant natural killer T cells in cardiovascular diseases with immunological and inflammatory backgrounds. Int Immunol 36:dxae019","journal-title":"Int Immunol"},{"issue":"1","key":"1593_CR73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"MA Jackson","year":"2018","unstructured":"Jackson MA et al (2018) Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat Commun 9(1):1\u20138","journal-title":"Nat Commun"},{"issue":"3","key":"1593_CR74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247378","volume":"16","author":"JD Jaimes","year":"2021","unstructured":"Jaimes JD et al (2021) Stool metabolome-microbiota evaluation among children and adolescents with obesity, overweight, and normal-weight using 1H NMR and 16S rRNA gene profiling. PLoS ONE 16(3):e0247378","journal-title":"PLoS ONE"},{"issue":"1","key":"1593_CR75","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s10020-024-00895-8","volume":"30","author":"JW Jang","year":"2024","unstructured":"Jang JW et al (2024) Trimethylamine N-oxide: a meta-organismal axis linking the gut and fibrosis. Mol Med 30(1):128","journal-title":"Mol Med"},{"key":"1593_CR76","doi-asserted-by":"publisher","DOI":"10.1111\/febs.17124","author":"M Jans","year":"2024","unstructured":"Jans M, Vereecke L (2024) A guide to germ-free and gnotobiotic mouse technology to study health and disease. FEBS J. https:\/\/doi.org\/10.1111\/febs.17124","journal-title":"FEBS J"},{"key":"1593_CR77","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c02568","author":"Y Jeong","year":"2024","unstructured":"Jeong Y et al (2024) Microbial \u03b2-glucuronidase hydrogel beads activate chemotherapeutic prodrug. ACS Appl Mater Interfaces. https:\/\/doi.org\/10.1021\/acsami.4c02568","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"1593_CR78","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.tim.2022.08.003","volume":"31","author":"B Jia","year":"2023","unstructured":"Jia B et al (2023) Gut microbiome-mediated mechanisms for reducing cholesterol levels: implications for ameliorating cardiovascular disease. Trends Microbiol 31(1):76\u201391","journal-title":"Trends Microbiol"},{"issue":"1","key":"1593_CR79","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1038\/s41467-024-45473-y","volume":"15","author":"L Jia","year":"2024","unstructured":"Jia L et al (2024) Porphyromonas gingivalis aggravates colitis via a gut microbiota-linoleic acid metabolism-Th17\/Treg cell balance axis. Nat Commun 15(1):1617","journal-title":"Nat Commun"},{"issue":"4","key":"1593_CR80","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/dmd.123.001605","volume":"52","author":"P Jimonet","year":"2024","unstructured":"Jimonet P et al (2024) Gut microbiome integration in drug discovery and development of small molecules. Drug Metab Dispos 52(4):274\u2013287","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"1593_CR81","first-page":"154","volume":"34","author":"H Jin","year":"2018","unstructured":"Jin H et al (2018) The influence of benazepril and amlodipine on the expression of secretin and somatostatin in spontaneously hypertensive rats. Chin J Appl Physiol 34(2):154\u2013158","journal-title":"Chin J Appl Physiol"},{"issue":"1","key":"1593_CR82","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1186\/s12967-024-05120-y","volume":"22","author":"Q Jin","year":"2024","unstructured":"Jin Q et al (2024) Quinic acid regulated TMA\/TMAO-related lipid metabolism and vascular endothelial function through gut microbiota to inhibit atherosclerotic. J Transl Med 22(1):352","journal-title":"J Transl Med"},{"issue":"1","key":"1593_CR83","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/infdis\/jiad537","volume":"229","author":"J Jo","year":"2024","unstructured":"Jo J et al (2024) Fecal pharmacokinetics and gut microbiome effects of oral omadacycline versus vancomycin in healthy volunteers. J Infect Dis 229(1):273\u2013281","journal-title":"J Infect Dis"},{"issue":"2","key":"1593_CR84","first-page":"18","volume":"48","author":"JL Johnson","year":"2023","unstructured":"Johnson JL, Weldon AJ (2023) Interactions between the gut microbiota and common cardiovascular drugs. US Pharm 48(2):18\u201321","journal-title":"US Pharm"},{"issue":"17","key":"1593_CR85","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1161\/CIRCULATIONAHA.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM et al (2020) Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation 141(17):1393\u20131403","journal-title":"Circulation"},{"key":"1593_CR86","doi-asserted-by":"crossref","first-page":"114561","DOI":"10.1016\/j.addr.2022.114561","volume":"191","author":"W-R Ke","year":"2022","unstructured":"Ke W-R, Chang RYK, Chan H-K (2022) Engineering the right formulation for enhanced drug delivery. Adv Drug Delivery Rev 191:114561","journal-title":"Adv Drug Delivery Rev"},{"issue":"4","key":"1593_CR87","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1161\/HYPERTENSIONAHA.114.03469","volume":"64","author":"S Khalesi","year":"2014","unstructured":"Khalesi S et al (2014) Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials. Hypertension 64(4):897\u2013903","journal-title":"Hypertension"},{"key":"1593_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01070-6","author":"MP Khuu","year":"2024","unstructured":"Khuu MP et al (2024) The gut microbiota in thrombosis. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-024-01070-6","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"1593_CR89","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/03602532.2023.2197178","volume":"55","author":"D-H Kim","year":"2023","unstructured":"Kim D-H (2023) Interaction of drugs with gut microbiota modulators. Drug Metab Rev 55(3):181\u2013194","journal-title":"Drug Metab Rev"},{"key":"1593_CR90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bcp.2016.09.023","volume":"122","author":"IS Kim","year":"2016","unstructured":"Kim IS et al (2016) Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin. Biochem Pharmacol 122:72\u201379","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"1593_CR91","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1042\/CS20180087","volume":"132","author":"S Kim","year":"2018","unstructured":"Kim S et al (2018) Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure. Clin Sci 132(6):701\u2013718","journal-title":"Clin Sci"},{"issue":"2","key":"1593_CR92","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/cvr\/cvab030","volume":"118","author":"M Kim","year":"2022","unstructured":"Kim M, Huda MN, Bennett BJ (2022) Sequence meets function\u2014microbiota and cardiovascular disease. Cardiovasc Res 118(2):399\u2013412","journal-title":"Cardiovasc Res"},{"issue":"1","key":"1593_CR93","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1038\/s41598-023-31684-8","volume":"13","author":"JE Kim","year":"2023","unstructured":"Kim JE et al (2023) Microbial diversity and metabolic function in duodenum, jejunum and ileum of emu (Dromaius novaehollandiae). Sci Rep 13(1):4488","journal-title":"Sci Rep"},{"issue":"6","key":"1593_CR94","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41440-022-00907-2","volume":"45","author":"T Kiyohara","year":"2022","unstructured":"Kiyohara T, Ago T (2022) Can calcium channel blockers prevent ischemic stroke in nonvalvular atrial fibrillation patients?\u2014the optimal choice of antihypertensive drug for subtype-specific stroke prevention. Hypertens Res 45(6):1076\u20131078","journal-title":"Hypertens Res"},{"issue":"7877","key":"1593_CR95","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41586-021-03891-8","volume":"597","author":"M Kl\u00fcnemann","year":"2021","unstructured":"Kl\u00fcnemann M et al (2021) Bioaccumulation of therapeutic drugs by human gut bacteria. Nature 597(7877):533\u2013538","journal-title":"Nature"},{"issue":"4","key":"1593_CR96","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1080\/1354750X.2018.1432689","volume":"23","author":"M Konop","year":"2018","unstructured":"Konop M et al (2018) Enalapril decreases rat plasma concentration of TMAO, a gut bacteria-derived cardiovascular marker. Biomarkers 23(4):380\u2013385","journal-title":"Biomarkers"},{"issue":"2","key":"1593_CR97","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/ATVBAHA.123.319458","volume":"44","author":"K Koponen","year":"2024","unstructured":"Koponen K et al (2024) Role of gut microbiota in statin-associated new-onset diabetes\u2014a cross-sectional and prospective analysis of the FINRISK 2002 cohort. Arterioscler Thromb Vasc Biol 44(2):477\u2013487","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"1593_CR98","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41575-023-00864-2","volume":"21","author":"O Koren","year":"2024","unstructured":"Koren O et al (2024) The maternal gut microbiome in pregnancy: implications for the developing immune system. Nat Rev Gastroenterol Hepatol 21(1):35\u201345","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1593_CR99","doi-asserted-by":"crossref","first-page":"101755","DOI":"10.1016\/j.smim.2023.101755","volume":"67","author":"LV Kovtonyuk","year":"2023","unstructured":"Kovtonyuk LV, McCoy KD (2023) Microbial metabolites and immunotherapy: basic rationale and clinical indications. Semin Immunol 67:101755","journal-title":"Semin Immunol"},{"key":"1593_CR100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-981-97-1844-3_3","volume-title":"Multi-omics analysis of the human microbiome: from technology to clinical applications","author":"A Kumar","year":"2024","unstructured":"Kumar A, Yadav A (2024) Next generation sequencing in metagenomics and metatranscriptomics. Multi-omics analysis of the human microbiome: from technology to clinical applications. Springer, pp 49\u201375"},{"issue":"6","key":"1593_CR101","doi-asserted-by":"crossref","first-page":"110122","DOI":"10.1016\/j.isci.2024.110122","volume":"27","author":"TS Kyaw","year":"2024","unstructured":"Kyaw TS et al (2024) Human gut Actinobacteria boost drug absorption by secreting P-glycoprotein ATPase inhibitors. Iscience 27(6):110122","journal-title":"Iscience"},{"issue":"9","key":"1593_CR102","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41440-022-00921-4","volume":"45","author":"J Kyoung","year":"2022","unstructured":"Kyoung J, Yang T (2022) Depletion of the gut microbiota enhances the blood pressure-lowering effect of captopril: implication of the gut microbiota in resistant hypertension. Hypertens Res 45(9):1505\u20131510","journal-title":"Hypertens Res"},{"key":"1593_CR103","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/gmb.2021.3","volume":"2","author":"D La Torre","year":"2021","unstructured":"La Torre D, Verbeke K, Dalile B (2021) Dietary fibre and the gut-brain axis: microbiota-dependent and independent mechanisms of action. Gut Microbiome 2:e3","journal-title":"Gut Microbiome"},{"key":"1593_CR104","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41577-023-00981-8","volume":"24","author":"MH Lee","year":"2024","unstructured":"Lee MH et al (2024) How bile acids and the microbiota interact to shape host immunity. Nat Rev Immunol 24:1\u201312","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"1593_CR105","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00284-023-03451-5","volume":"80","author":"NK Lema","year":"2023","unstructured":"Lema NK, Gemeda MT, Woldesemayat AA (2023) Recent advances in metagenomic approaches, applications, and challenges. Curr Microbiol 80(11):347","journal-title":"Curr Microbiol"},{"issue":"16","key":"1593_CR106","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029230","volume":"12","author":"RN Lemaitre","year":"2023","unstructured":"Lemaitre RN et al (2023) Plasma trimethylamine-N-oxide and incident ischemic stroke: the cardiovascular health study and the multi-ethnic study of atherosclerosis. J Am Heart Assoc 12(16):e8711","journal-title":"J Am Heart Assoc"},{"key":"1593_CR107","volume":"153","author":"A-M Lewis-Mikhael","year":"2020","unstructured":"Lewis-Mikhael A-M, Davoodvandi A, Jafarnejad S (2020) Effect of Lactobacillusplantarum containing probiotics on blood pressure: a systematic review and meta-analysis. Pharmacol Res 153:104663","journal-title":"Pharmacol Res"},{"issue":"5","key":"1593_CR108","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1161\/HYPERTENSIONAHA.120.14736","volume":"75","author":"H-B Li","year":"2020","unstructured":"Li H-B et al (2020) Maternal treatment with captopril persistently alters gut-brain communication and attenuates hypertension of male offspring. Hypertension 75(5):1315\u20131324","journal-title":"Hypertension"},{"issue":"4","key":"1593_CR109","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/gutjnl-2020-322473","volume":"71","author":"J Li","year":"2022","unstructured":"Li J et al (2022a) Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: findings from a longitudinal cohort of US men. Gut 71(4):724\u2013733","journal-title":"Gut"},{"issue":"9","key":"1593_CR110","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1111\/bph.15768","volume":"179","author":"Y Li","year":"2022","unstructured":"Li Y et al (2022b) Amlodipine, an anti-hypertensive drug, alleviates non-alcoholic fatty liver disease by modulating gut microbiota. Br J Pharmacol 179(9):2054\u20132077","journal-title":"Br J Pharmacol"},{"issue":"2","key":"1593_CR111","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.chom.2023.12.015","volume":"32","author":"T Li","year":"2024","unstructured":"Li T et al (2024) A gut microbiota-bile acid axis promotes intestinal homeostasis upon aspirin-mediated damage. Cell Host Microbe 32(2):191-208.e9","journal-title":"Cell Host Microbe"},{"issue":"6","key":"1593_CR112","doi-asserted-by":"crossref","first-page":"2300443","DOI":"10.1002\/mnfr.202300443","volume":"68","author":"XY Li","year":"2024","unstructured":"Li XY et al (2024) Gut microbiota metabolite TMA may mediate the effects of TMAO on glucose and lipid metabolism in C57BL\/6J mice. Mol Nutr Food Res 68(6):2300443","journal-title":"Mol Nutr Food Res"},{"key":"1593_CR113","doi-asserted-by":"crossref","first-page":"1374775","DOI":"10.3389\/fcimb.2024.1374775","volume":"14","author":"J Liang","year":"2024","unstructured":"Liang J et al (2024) Causal relationships between gut microbiota and lymphoma: a bidirectional Mendelian randomization study. Front Cell Infect Microbiol 14:1374775","journal-title":"Front Cell Infect Microbiol"},{"issue":"14","key":"1593_CR114","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJM198110013051403","volume":"305","author":"J Lindenbaum","year":"1981","unstructured":"Lindenbaum J et al (1981) Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 305(14):789\u2013794","journal-title":"N Engl J Med"},{"issue":"4","key":"1593_CR115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/10641963.2018.1481420","volume":"41","author":"M Liu","year":"2019","unstructured":"Liu M, Han Q, Yang J (2019) Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats. Clin Exp Hypertens 41(4):312\u2013322","journal-title":"Clin Exp Hypertens"},{"issue":"25","key":"1593_CR116","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.3748\/wjg.v27.i25.3837","volume":"27","author":"B-N Liu","year":"2021","unstructured":"Liu B-N et al (2021) Gut microbiota in obesity. World J Gastroenterol 27(25):3837","journal-title":"World J Gastroenterol"},{"issue":"2","key":"1593_CR117","first-page":"14336","volume":"13","author":"J Liu","year":"2022","unstructured":"Liu J et al (2022) Functions of gut microbiota metabolites, current status and future perspectives. Aging Dis 13(2):14336","journal-title":"Aging Dis"},{"issue":"1","key":"1593_CR118","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/aro2.7","volume":"1","author":"C Liu","year":"2023","unstructured":"Liu C et al (2023) From probiotics to postbiotics: concepts and applications. Anim Res One Health 1(1):92\u2013114","journal-title":"Anim Res One Health"},{"key":"1593_CR119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.thromres.2023.11.003","volume":"233","author":"L Liu","year":"2024","unstructured":"Liu L et al (2024a) Trimethylamine-N-oxide (TMAO) and basic fibroblast growth factor (bFGF) are possibly involved in corticosteroid resistance in adult patients with immune thrombocytopenia. Thromb Res 233:25\u201336","journal-title":"Thromb Res"},{"issue":"1","key":"1593_CR120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41420-024-02064-6","volume":"10","author":"J Liu","year":"2024","unstructured":"Liu J et al (2024b) The roles of Th cells in myocardial infarction. Cell Death Discov 10(1):287","journal-title":"Cell Death Discov"},{"key":"1593_CR121","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2024.02.003","author":"J Liu","year":"2024","unstructured":"Liu J, Kang R, Tang D (2024c) Lipopolysaccharide delivery systems in innate immunity. Trends Immunol. https:\/\/doi.org\/10.1016\/j.it.2024.02.003","journal-title":"Trends Immunol"},{"issue":"1","key":"1593_CR122","doi-asserted-by":"crossref","first-page":"2316923","DOI":"10.1080\/19490976.2024.2316923","volume":"16","author":"X Liu","year":"2024","unstructured":"Liu X et al (2024d) S-amlodipine induces liver inflammation and dysfunction through the alteration of intestinal microbiome in a rat model. Gut Microbes 16(1):2316923","journal-title":"Gut Microbes"},{"issue":"5","key":"1593_CR123","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.3390\/agronomy14051003","volume":"14","author":"E Lodygin","year":"2024","unstructured":"Lodygin E, Abakumov E (2024) The use of spectroscopic methods to study organic matter in virgin and arable soils: a scoping review. Agronomy 14(5):1003","journal-title":"Agronomy"},{"issue":"10","key":"1593_CR124","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11886-021-01580-6","volume":"23","author":"CM Lombardi","year":"2021","unstructured":"Lombardi CM et al (2021) Vericiguat for heart failure with reduced ejection fraction. Curr Cardiol Rep 23(10):1\u20137","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"1593_CR125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40168-024-01797-x","volume":"12","author":"K Luo","year":"2024","unstructured":"Luo K et al (2024) Gut microbiota, blood metabolites, and left ventricular diastolic dysfunction in US Hispanics\/Latinos. Microbiome 12(1):85","journal-title":"Microbiome"},{"issue":"8","key":"1593_CR126","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/cells12081158","volume":"12","author":"VV Lupu","year":"2023","unstructured":"Lupu VV et al (2023) The implication of the gut microbiome in heart failure. Cells 12(8):1158","journal-title":"Cells"},{"key":"1593_CR127","doi-asserted-by":"crossref","first-page":"1321395","DOI":"10.3389\/fimmu.2024.1321395","volume":"15","author":"A Luqman","year":"2024","unstructured":"Luqman A et al (2024) Role of the intestinal microbiome and its therapeutic intervention in cardiovascular disorder. Front Immunol 15:1321395","journal-title":"Front Immunol"},{"key":"1593_CR128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-024-01206-6","volume":"26","author":"KA Lusta","year":"2024","unstructured":"Lusta KA et al (2024) The role of bacterial extracellular membrane nanovesicles in atherosclerosis: unraveling a potential trigger. Curr Atheroscler Rep 26:1\u201316","journal-title":"Curr Atheroscler Rep"},{"key":"1593_CR129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41577-023-00981-8","volume":"24","author":"ER Mann","year":"2024","unstructured":"Mann ER, Lam YK, Uhlig HH (2024) Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol 24:1\u201319","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"1593_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-022-03468-9","volume":"5","author":"F Marrocco","year":"2022","unstructured":"Marrocco F et al (2022) Short-chain fatty acids promote the effect of environmental signals on the gut microbiome and metabolome in mice. Commun Biol 5(1):1\u201313","journal-title":"Commun Biol"},{"issue":"8","key":"1593_CR131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11906-023-01245-5","volume":"25","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Kirabo A (2023) Salt and gut microbiota in heart failure. Curr Hypertens Rep 25(8):173\u2013184","journal-title":"Curr Hypertens Rep"},{"key":"1593_CR132","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41371-022-00698-6","volume":"36","author":"SK Masenga","year":"2022","unstructured":"Masenga SK et al (2022) Recent advances in modulation of cardiovascular diseases by the gut microbiota. J Hum Hypertens 36:1\u20138","journal-title":"J Hum Hypertens"},{"key":"1593_CR133","doi-asserted-by":"publisher","DOI":"10.1113\/EP091962","author":"MJ McKenna","year":"2024","unstructured":"McKenna MJ et al (2024) Digoxin and exercise effects on skeletal muscle Na+, K+-ATPase isoform gene expression in healthy humans. Exp Physiol. https:\/\/doi.org\/10.1113\/EP091962","journal-title":"Exp Physiol"},{"issue":"6","key":"1593_CR134","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/dmd.121.000417","volume":"50","author":"JM Migliorati","year":"2022","unstructured":"Migliorati JM et al (2022) Absorption, distribution, metabolism, and excretion of US Food and Drug Administration-approved antisense oligonucleotide drugs. Drug Metab Dispos 50(6):888\u2013897","journal-title":"Drug Metab Dispos"},{"issue":"25","key":"1593_CR135","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jacc.2024.04.030","volume":"83","author":"MB Mortensen","year":"2024","unstructured":"Mortensen MB et al (2024) Association of autoimmune diseases with coronary atherosclerosis severity and ischemic events. J Am Coll Cardiol 83(25):2643\u20132654","journal-title":"J Am Coll Cardiol"},{"key":"1593_CR136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13668-024-00531-1","volume":"13","author":"SS Mousavi Ghahfarrokhi","year":"2024","unstructured":"Mousavi Ghahfarrokhi SS et al (2024) Management of cardiovascular diseases by short-chain fatty acid postbiotics. Curr Nutr Rep 13:1\u201320","journal-title":"Curr Nutr Rep"},{"key":"1593_CR137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41440-023-01533-2","volume":"47","author":"Y-F Mu","year":"2024","unstructured":"Mu Y-F et al (2024) Perspectives on the involvement of the gut microbiota in salt-sensitive hypertension. Hypertens Res 47:1\u201312","journal-title":"Hypertens Res"},{"issue":"41","key":"1593_CR138","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1093\/eurheartj\/ehaa745","volume":"41","author":"T M\u00fcnzel","year":"2020","unstructured":"M\u00fcnzel T et al (2020) Reduction of environmental pollutants for prevention of cardiovascular disease: it\u2019s time to act. Eur Heart J 41(41):3989","journal-title":"Eur Heart J"},{"key":"1593_CR139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/978-981-97-1777-4_11","volume-title":"Translational research in biomedical sciences: recent progress and future prospects","author":"S Murthy","year":"2024","unstructured":"Murthy S et al (2024) Clinical translation of microbe-based therapies. Translational research in biomedical sciences: recent progress and future prospects. Springer, Cham, pp 167\u2013181"},{"key":"1593_CR140","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111156","volume":"134","author":"S Naqvi","year":"2021","unstructured":"Naqvi S et al (2021) A cross-talk between gut microbiome, salt and hypertension. Biomed Pharmacother 134:111156","journal-title":"Biomed Pharmacother"},{"issue":"17","key":"1593_CR141","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1136\/heartjnl-2024-323948","volume":"110","author":"MR Nelson","year":"2024","unstructured":"Nelson MR, Black JA (2024) Aspirin: latest evidence and developments. Heart 110(17):1069\u20131073","journal-title":"Heart"},{"key":"1593_CR142","doi-asserted-by":"crossref","first-page":"1403150","DOI":"10.3389\/fimmu.2024.1403150","volume":"15","author":"D Ngai","year":"2024","unstructured":"Ngai D, Sukka SR, Tabas I (2024) Crosstalk between efferocytic myeloid cells and T-cells and its relevance to atherosclerosis. Front Immunol 15:1403150","journal-title":"Front Immunol"},{"issue":"36","key":"1593_CR143","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.3748\/wjg.v25.i36.5543","volume":"25","author":"E Niccolai","year":"2019","unstructured":"Niccolai E et al (2019) Evaluation and comparison of short chain fatty acids composition in gut diseases. World J Gastroenterol 25(36):5543","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1593_CR144","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.embor.7400731","volume":"7","author":"AM O\u2019Hara","year":"2006","unstructured":"O\u2019Hara AM, Shanahan F (2006) The gut flora as a forgotten organ. EMBO Rep 7(7):688\u2013693","journal-title":"EMBO Rep"},{"key":"1593_CR145","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-3-031-57361-3_41","volume-title":"Frailty: a multidisciplinary approach to assessment, management, and prevention","author":"DE O\u2019Neill","year":"2024","unstructured":"O\u2019Neill DE, Forman DE (2024) Frailty and cardiovascular disease. Frailty: a multidisciplinary approach to assessment, management, and prevention. Springer, pp 299\u2013308"},{"key":"1593_CR146","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01694-2021","author":"T Ogo","year":"2022","unstructured":"Ogo T et al (2022) Selexipag for the treatment of chronic thromboembolic pulmonary hypertension. Eur Respir J. https:\/\/doi.org\/10.1183\/13993003.01694-2021","journal-title":"Eur Respir J"},{"issue":"10253","key":"1593_CR147","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","volume":"396","author":"I Olivotto","year":"2020","unstructured":"Olivotto I et al (2020) Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 396(10253):759\u2013769","journal-title":"Lancet"},{"key":"1593_CR148","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/978-3-030-74720-6_25","volume-title":"Geriatric medicine: a person centered evidence based approach","author":"I Onuorah","year":"2024","unstructured":"Onuorah I, Agrawal A, Wenger N (2024) Management of cardiovascular disease in the elderly. Geriatric medicine: a person centered evidence based approach. Springer, pp 343\u2013383"},{"issue":"9","key":"1593_CR149","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.tim.2023.03.018","volume":"31","author":"X Pan","year":"2023","unstructured":"Pan X, Raaijmakers JM, Carri\u00f3n VJ (2023) Importance of Bacteroidetes in host\u2013microbe interactions and ecosystem functioning. Trends Microbiol 31(9):959\u2013971","journal-title":"Trends Microbiol"},{"issue":"1","key":"1593_CR150","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00248-022-02081-x","volume":"86","author":"A Pant","year":"2023","unstructured":"Pant A et al (2023) Human gut microbiota and drug metabolism. Microb Ecol 86(1):97\u2013111","journal-title":"Microb Ecol"},{"key":"1593_CR151","volume":"1130","author":"\u0141 Paprotny","year":"2019","unstructured":"Paprotny \u0141 et al (2019) Development and validation of GC\u2013MS\/MS method useful in diagnosing intestinal dysbiosis. J Chromatogr B 1130:121822","journal-title":"J Chromatogr B"},{"issue":"3","key":"1593_CR152","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.3390\/ijms25031716","volume":"25","author":"I Paraskevaidis","year":"2024","unstructured":"Paraskevaidis I, Briasoulis A, Tsougos E (2024) Oral cardiac drug-gut microbiota interaction in chronic heart failure patients: an emerging association. Int J Mol Sci 25(3):1716","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1593_CR153","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/mi.2014.44","volume":"8","author":"J Park","year":"2015","unstructured":"Park J et al (2015) Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR\u2013S6K pathway. Mucosal Immunol 8(1):80\u201393","journal-title":"Mucosal Immunol"},{"key":"1593_CR154","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1201\/9781003452249-6","volume-title":"Probiotics","author":"PH Patel","year":"2024","unstructured":"Patel PH et al (2024) Probiotics in pharmacology: drug delivery, pharmacokinetics, and mechanism involved. Probiotics. CRC Press, Boca Raton, pp 129\u2013145"},{"issue":"4","key":"1593_CR155","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jama.2022.7408","volume":"328","author":"CD Patnode","year":"2022","unstructured":"Patnode CD et al (2022) Behavioral counseling interventions to promote a healthy diet and physical activity for cardiovascular disease prevention in adults without known cardiovascular disease risk factors: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA 328(4):375\u2013388","journal-title":"JAMA"},{"key":"1593_CR156","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/B978-0-443-15842-1.00024-7","volume-title":"Public health and toxicology issues drug research","author":"V Pawar","year":"2024","unstructured":"Pawar V et al (2024) Drug-induced cardiotoxicity. Public health and toxicology issues drug research, vol 2. Elsevier, pp 253\u2013282"},{"key":"1593_CR157","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-024-00746-6","author":"Y Pinto","year":"2024","unstructured":"Pinto Y, Bhatt AS (2024) Sequencing-based analysis of microbiomes. Nat Rev Genet. https:\/\/doi.org\/10.1038\/s41576-024-00746-6","journal-title":"Nat Rev Genet"},{"key":"1593_CR158","first-page":"1","volume":"35","author":"R-AG Pushpass","year":"2021","unstructured":"Pushpass R-AG et al (2021) Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods. Nutr Res Rev 35:1\u201354","journal-title":"Nutr Res Rev"},{"issue":"5","key":"1593_CR159","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41579-023-00998-9","volume":"22","author":"K Ratiner","year":"2024","unstructured":"Ratiner K et al (2024) Utilization of the microbiome in personalized medicine. Nat Rev Microbiol 22(5):291\u2013308","journal-title":"Nat Rev Microbiol"},{"issue":"16","key":"1593_CR160","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","volume":"382","author":"KK Ray","year":"2020","unstructured":"Ray KK et al (2020) Two phase 3 trials of inclisiran in patients with elevated LDL cholesterol. N Engl J Med 382(16):1507\u20131519","journal-title":"N Engl J Med"},{"key":"1593_CR161","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3389\/fimmu.2021.719517","volume":"12","author":"E Reali","year":"2021","unstructured":"Reali E, Ferrando-Martinez S, Catalfamo M (2021) The interplay between immune activation and cardiovascular disease during infection, autoimmunity and aging: the role of T cells. Front Immunol 12:2497","journal-title":"Front Immunol"},{"issue":"11","key":"1593_CR162","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1194\/jlr.M200144-JLR200","volume":"43","author":"JJ Repa","year":"2002","unstructured":"Repa JJ, Dietschy JM, Turley SD (2002) Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte. J Lipid Res 43(11):1864\u20131874","journal-title":"J Lipid Res"},{"issue":"9750","key":"1593_CR163","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(10)61267-6","volume":"376","author":"S Ripatti","year":"2010","unstructured":"Ripatti S et al (2010) A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses. The Lancet 376(9750):1393\u20131400","journal-title":"The Lancet"},{"issue":"9","key":"1593_CR164","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/bph.14965","volume":"177","author":"I Robles-Vera","year":"2020","unstructured":"Robles-Vera I et al (2020) Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects. Br J Pharmacol 177(9):2006\u20132023","journal-title":"Br J Pharmacol"},{"key":"1593_CR165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41586-024-07754-w","volume":"632","author":"B Roje","year":"2024","unstructured":"Roje B et al (2024) Gut microbiota carcinogen metabolism causes distal tissue tumours. Nature 632:1\u20138","journal-title":"Nature"},{"issue":"11","key":"1593_CR166","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1160\/TH11-06-0392","volume":"106","author":"ME Rosenfeld","year":"2011","unstructured":"Rosenfeld ME, Campbell LA (2011) Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106(11):858\u2013867","journal-title":"Thromb Haemost"},{"issue":"8","key":"1593_CR167","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1161\/CIRCRESAHA.116.307709","volume":"118","author":"MM Santisteban","year":"2016","unstructured":"Santisteban MM et al (2016) Brain\u2013gut\u2013bone marrow axis: implications for hypertension and related therapeutics. Circ Res 118(8):1327\u20131336","journal-title":"Circ Res"},{"issue":"2","key":"1593_CR168","doi-asserted-by":"crossref","first-page":"e2148147","DOI":"10.1001\/jamanetworkopen.2021.48147","volume":"5","author":"RD Santos","year":"2022","unstructured":"Santos RD (2022) Calcified and noncalcified coronary plaques and atherosclerotic cardiovascular events in patients with severe hypercholesterolemia\u2014moving forward with risk stratification and therapy. JAMA Netw Open 5(2):e2148147\u2013e2148147","journal-title":"JAMA Netw Open"},{"key":"1593_CR169","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2022.132809","volume":"374","author":"M Shang","year":"2023","unstructured":"Shang M et al (2023) A portable kit for rapid detection of bromadiolone in human blood and urine via surface-enhanced raman scattering coupled with salt-induced liquid-liquid phase separation. Sens Actuators, B Chem 374:132809","journal-title":"Sens Actuators, B Chem"},{"issue":"1","key":"1593_CR170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2891-12-138","volume":"12","author":"KK Sharafedtinov","year":"2013","unstructured":"Sharafedtinov KK et al (2013) Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study. Nutr J 12(1):1\u201311","journal-title":"Nutr J"},{"issue":"5","key":"1593_CR171","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1097\/MS9.0000000000001744","volume":"86","author":"S Shariff","year":"2024","unstructured":"Shariff S et al (2024) Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease. Ann Med Surg 86(5):2752\u20132758","journal-title":"Ann Med Surg"},{"issue":"14","key":"1593_CR172","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2174\/0113816128302001240321044409","volume":"30","author":"RA Sheikh","year":"2024","unstructured":"Sheikh RA et al (2024) Zamzam water mitigates cardiac toxicity risk through modulation of GUT microbiota and the renin-angiotensin system. Curr Pharm Des 30(14):1115\u20131127","journal-title":"Curr Pharm Des"},{"issue":"5","key":"1593_CR173","volume":"36","author":"H Shi","year":"2022","unstructured":"Shi H et al (2022) Controlled dual release of dihydrotestosterone and flutamide from polycaprolactone electrospun scaffolds accelerate burn wound healing. FASEB J 36(5):e22310","journal-title":"FASEB J"},{"key":"1593_CR174","doi-asserted-by":"crossref","unstructured":"Shukla R, Singh S, Mishra K (2024) Remedial measures for neurodegenerative diseases targeting gut-microbial dysfunction with herbal bio-actives. In: Proceedings of the National Academy of Sciences, India section b: biological sciences. p. 1\u201315","DOI":"10.1007\/s40011-023-01527-7"},{"issue":"8","key":"1593_CR175","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.3390\/cancers15082352","volume":"15","author":"N Silva-Pilipich","year":"2023","unstructured":"Silva-Pilipich N, Covo-Vergara \u00c1, Smerdou C (2023) Local delivery of immunomodulatory antibodies for gastrointestinal tumors. Cancers 15(8):2352","journal-title":"Cancers"},{"issue":"17","key":"1593_CR176","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.cell.2024.06.028","volume":"187","author":"A Simats","year":"2024","unstructured":"Simats A et al (2024) Innate immune memory after brain injury drives inflammatory cardiac dysfunction. Cell 187(17):4637-4655.e26","journal-title":"Cell"},{"issue":"2","key":"1593_CR177","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1001\/jamaoncol.2018.4628","volume":"5","author":"LL Siu","year":"2019","unstructured":"Siu LL et al (2019) Safety and efficacy of durvalumab with or without tremelimumab in patients with PD-L1\u2013low\/negative recurrent or metastatic HNSCC: the phase 2 CONDOR randomized clinical trial. JAMA Oncol 5(2):195\u2013203","journal-title":"JAMA Oncol"},{"key":"1593_CR178","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pharmthera.2016.04.007","volume":"164","author":"S Sivaprakasam","year":"2016","unstructured":"Sivaprakasam S, Prasad PD, Singh N (2016) Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis. Pharmacol Ther 164:144\u2013151","journal-title":"Pharmacol Ther"},{"key":"1593_CR179","doi-asserted-by":"crossref","DOI":"10.1002\/9781119904786","volume-title":"The gut microbiota in health and disease","author":"N Srivastava","year":"2023","unstructured":"Srivastava N et al (2023) The gut microbiota in health and disease. John Wiley & Sons, Hoboken"},{"issue":"2","key":"1593_CR180","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/phar.2650","volume":"42","author":"HE Steiner","year":"2022","unstructured":"Steiner HE et al (2022) Role of the gut microbiome in cardiovascular drug response: The potential for clinical application. Pharmacother J Hum Pharmacol Drug Ther 42(2):165\u2013176","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"issue":"5","key":"1593_CR181","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","volume":"73","author":"S Sun","year":"2019","unstructured":"Sun S et al (2019) Gut microbiota composition and blood pressure: the CARDIA study. Hypertension 73(5):998\u20131006","journal-title":"Hypertension"},{"issue":"3","key":"1593_CR182","volume":"15","author":"Y Sun","year":"2020","unstructured":"Sun Y et al (2020) Effects of intestinal flora on the pharmacokinetics and pharmacodynamics of aspirin in high-altitude hypoxia. PLoS ONE 15(3):e0230197","journal-title":"PLoS ONE"},{"issue":"1","key":"1593_CR183","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1146\/annurev-immunol-090222-102035","volume":"42","author":"T Takeuchi","year":"2024","unstructured":"Takeuchi T, Nakanishi Y, Ohno H (2024) Microbial metabolites and gut immunology. Annu Rev Immunol 42(1):153\u2013178","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1593_CR184","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13318-023-00874-0","volume":"49","author":"J Tan","year":"2024","unstructured":"Tan J et al (2024) Novel techniques and models for studying the role of the gut microbiota in drug metabolism. Eur J Drug Metab Pharmacokinet 49(2):131\u2013147","journal-title":"Eur J Drug Metab Pharmacokinet"},{"issue":"1","key":"1593_CR185","doi-asserted-by":"crossref","first-page":"2387402","DOI":"10.1080\/19490976.2024.2387402","volume":"16","author":"D Tang","year":"2024","unstructured":"Tang D et al (2024) Gut microbiota-mediated C-sulfonate metabolism impairs the bioavailability and anti-cholestatic efficacy of andrographolide. Gut Microbes 16(1):2387402","journal-title":"Gut Microbes"},{"issue":"6","key":"1593_CR186","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41385-022-00562-3","volume":"15","author":"CA Thomson","year":"2022","unstructured":"Thomson CA et al (2022) From germ-free to wild: modulating microbiome complexity to understand mucosal immunology. Mucosal Immunol 15(6):1085\u20131094","journal-title":"Mucosal Immunol"},{"key":"1593_CR187","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-022724-100847","author":"KR Trepka","year":"2024","unstructured":"Trepka KR et al (2024) Pharma[e]cology: how the gut microbiome contributes to variations in drug response. Ann Rev Pharmacol Toxicol. https:\/\/doi.org\/10.1146\/annurev-pharmtox-022724-100847","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"1593_CR188","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3389\/fmed.2017.00163","volume":"4","author":"V Urdaneta","year":"2017","unstructured":"Urdaneta V, Casades\u00fas J (2017) Interactions between bacteria and bile salts in the gastrointestinal and hepatobiliary tracts. Front Med 4:163","journal-title":"Front Med"},{"issue":"2","key":"1593_CR189","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1053\/j.gastro.2021.11.017","volume":"162","author":"M Venzon","year":"2022","unstructured":"Venzon M, Cadwell K (2022) COVID-19 and the forgotten organ: prolonged changes to the metabolic output of the gut microbiome. Gastroenterology 162(2):394\u2013396","journal-title":"Gastroenterology"},{"key":"1593_CR190","doi-asserted-by":"crossref","first-page":"1213829","DOI":"10.3389\/fgene.2023.1213829","volume":"14","author":"C Waechter","year":"2023","unstructured":"Waechter C et al (2023) Comparative analysis of full-length 16s ribosomal RNA genome sequencing in human fecal samples using primer sets with different degrees of degeneracy. Front Genet 14:1213829","journal-title":"Front Genet"},{"issue":"7341","key":"1593_CR191","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang Z et al (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57\u201363","journal-title":"Nature"},{"issue":"19","key":"1593_CR192","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.3390\/foods13193183","volume":"13","author":"Z Wang","year":"2024","unstructured":"Wang Z et al (2024a) Effects of pine pollen polysaccharides and sulfated polysaccharides on ulcerative colitis in mice by regulating Th17\/Treg. Foods 13(19):3183","journal-title":"Foods"},{"issue":"2","key":"1593_CR193","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s12011-023-03693-1","volume":"202","author":"Y Wang","year":"2024","unstructured":"Wang Y et al (2024b) The involvement of lactic acid bacteria and their exopolysaccharides in the biosorption and detoxication of heavy metals in the gut. Biol Trace Elem Res 202(2):671\u2013684","journal-title":"Biol Trace Elem Res"},{"issue":"5","key":"1593_CR194","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000521770","volume":"146","author":"S Wei","year":"2022","unstructured":"Wei S et al (2022) Losartan attenuates atherosclerosis in uremic mice by regulating Treg\/Th17 balance via mediating PTEN\/PI3K\/Akt pathway. Nephron 146(5):528\u2013538","journal-title":"Nephron"},{"key":"1593_CR195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ebiom.2018.11.046","volume":"39","author":"A Whang","year":"2019","unstructured":"Whang A, Nagpal R, Yadav H (2019) Bi-directional drug-microbiome interactions of anti-diabetics. EBioMedicine 39:591\u2013602","journal-title":"EBioMedicine"},{"issue":"7682","key":"1593_CR196","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature24628","volume":"551","author":"N Wilck","year":"2017","unstructured":"Wilck N et al (2017) Salt-responsive gut commensal modulates TH17 axis and disease. Nature 551(7682):585\u2013589","journal-title":"Nature"},{"issue":"720","key":"1593_CR197","doi-asserted-by":"crossref","first-page":"eabo2750","DOI":"10.1126\/scitranslmed.abo2750","volume":"15","author":"MH Woodworth","year":"2023","unstructured":"Woodworth MH et al (2023) Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement. Sci Transl Med 15(720):eabo2750","journal-title":"Sci Transl Med"},{"issue":"9","key":"1593_CR198","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.jacc.2020.12.058","volume":"77","author":"RS Wright","year":"2021","unstructured":"Wright RS et al (2021) Pooled patient-level analysis of inclisiran trials in patients with familial hypercholesterolemia or atherosclerosis. J Am Coll Cardiol 77(9):1182\u20131193","journal-title":"J Am Coll Cardiol"},{"key":"1593_CR199","volume":"13","author":"S Wu","year":"2021","unstructured":"Wu S et al (2021) Roles and mechanisms of gut microbiota in patients with Alzheimer\u2019s disease. Front Aging Neurosci 13:650047","journal-title":"Front Aging Neurosci"},{"issue":"2","key":"1593_CR200","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41440-021-00796-x","volume":"45","author":"H Wu","year":"2022","unstructured":"Wu H et al (2022) Hypotensive effect of captopril on deoxycorticosterone acetate-salt-induced hypertensive rat is associated with gut microbiota alteration. Hypertens Res 45(2):270\u2013282","journal-title":"Hypertens Res"},{"key":"1593_CR201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-021-01157-2","volume":"23","author":"Y Xiong","year":"2021","unstructured":"Xiong Y et al (2021) The role of gut microbiota in hypertension pathogenesis and the efficacy of antihypertensive drugs. Curr Hypertens Rep 23:1\u201314","journal-title":"Curr Hypertens Rep"},{"key":"1593_CR202","first-page":"1","volume":"50","author":"Y Xu","year":"2023","unstructured":"Xu Y et al (2023) Targeting the gut microbiota to alleviate chemotherapy-induced toxicity in cancer. Crit Rev Microbiol 50:1\u201317","journal-title":"Crit Rev Microbiol"},{"issue":"1","key":"1593_CR203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12934-014-0183-3","volume":"14","author":"G Yang","year":"2015","unstructured":"Yang G et al (2015) Effective treatment of hypertension by recombinant Lactobacillus plantarum expressing angiotensin converting enzyme inhibitory peptide. Microb Cell Fact 14(1):1\u20139","journal-title":"Microb Cell Fact"},{"issue":"4","key":"1593_CR204","volume":"8","author":"T Yang","year":"2019","unstructured":"Yang T et al (2019) Sustained captopril-induced reduction in blood pressure is associated with alterations in gut-brain axis in the spontaneously hypertensive rat. J Am Heart Assoc 8(4):e010721","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"1593_CR205","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/00498254.2019.1673918","volume":"50","author":"J Yang","year":"2020","unstructured":"Yang J et al (2020) Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism. Xenobiotica 50(6):685\u2013688","journal-title":"Xenobiotica"},{"key":"1593_CR206","volume":"201","author":"J Ye","year":"2024","unstructured":"Ye J et al (2024) Chromatographic and mass spectrometric analytical strategies for profiling tyrosine kinase inhibitors in biological samples. Microchem J 201:110694","journal-title":"Microchem J"},{"key":"1593_CR207","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00404-022-06516-1","volume":"306","author":"J Yin","year":"2022","unstructured":"Yin J et al (2022) Nifedipine or amlodipine? The choice for hypertension during pregnancy: a systematic review and meta-analysis. Arch Gynecol Obstet 306:1\u201310","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1593_CR208","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/HJH.0000000000000773","volume":"34","author":"HH Yoo","year":"2016","unstructured":"Yoo HH et al (2016) Effects of orally administered antibiotics on the bioavailability of amlodipine: gut microbiota-mediated drug interaction. J Hypertens 34(1):156\u2013162","journal-title":"J Hypertens"},{"issue":"10","key":"1593_CR209","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/microorganisms8101587","volume":"8","author":"JY Yoo","year":"2020","unstructured":"Yoo JY et al (2020) Gut microbiota and immune system interactions. Microorganisms 8(10):1587","journal-title":"Microorganisms"},{"key":"1593_CR210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fnut.2019.00048","volume":"6","author":"K Yoshii","year":"2019","unstructured":"Yoshii K et al (2019) Metabolism of dietary and microbial vitamin B family in the regulation of host immunity. Front Nutr 6:48","journal-title":"Front Nutr"},{"issue":"7","key":"1593_CR211","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/1750-3841.15186","volume":"85","author":"ZL Yu","year":"2020","unstructured":"Yu ZL et al (2020) Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice. J Food Sci 85(7):2207\u20132215","journal-title":"J Food Sci"},{"issue":"1","key":"1593_CR212","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/10717544.2018.1469687","volume":"25","author":"J Zhang","year":"2018","unstructured":"Zhang J et al (2018) Plateau hypoxia attenuates the metabolic activity of intestinal flora to enhance the bioavailability of nifedipine. Drug Delivery 25(1):1175\u20131181","journal-title":"Drug Delivery"},{"issue":"1","key":"1593_CR213","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J et al (2019) Gut microbiota-mediated drug-drug interaction between amoxicillin and aspirin. Sci Rep 9(1):1\u20138","journal-title":"Sci Rep"},{"key":"1593_CR214","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.trsl.2020.08.007","volume":"228","author":"Y Zhang","year":"2021","unstructured":"Zhang Y et al (2021a) TMAO: how gut microbiota contributes to heart failure. Transl Res 228:109\u2013125","journal-title":"Transl Res"},{"issue":"7","key":"1593_CR215","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.apsb.2020.09.013","volume":"11","author":"X Zhang","year":"2021","unstructured":"Zhang X et al (2021b) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceut Sin B 11(7):1789\u20131812","journal-title":"Acta Pharmaceut Sin B"},{"issue":"14","key":"1593_CR216","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1016\/j.cell.2022.05.022","volume":"185","author":"Z Zhang","year":"2022","unstructured":"Zhang Z et al (2022) Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185(14):2434-2451.e17","journal-title":"Cell"},{"key":"1593_CR217","volume":"174","author":"Z Zhang","year":"2024","unstructured":"Zhang Z et al (2024) Role of the microbiota\u2013gut\u2013heart axis between bile acids and cardiovascular disease. Biomed Pharmacother 174:116567","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"1593_CR218","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41522-024-00498-5","volume":"10","author":"X-Y Zhang","year":"2024","unstructured":"Zhang X-Y et al (2024) Ginseng extracts improve circadian clock gene expression and reduce inflammation directly and indirectly through gut microbiota and PI3K signaling pathway. Npj Biofilms Microb 10(1):24","journal-title":"Npj Biofilms Microb"},{"issue":"3","key":"1593_CR219","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1053\/j.gastro.2020.05.004","volume":"159","author":"R Zhao","year":"2020","unstructured":"Zhao R et al (2020) Aspirin reduces colorectal tumor development in mice and gut microbes reduce its bioavailability and chemopreventive effects. Gastroenterology 159(3):969-983.e4","journal-title":"Gastroenterology"},{"key":"1593_CR220","first-page":"e010721","volume":"8","author":"T Zheng","year":"2022","unstructured":"Zheng T, Marques FZ (2022) Gut microbiota: friends or foes for blood pressure-lowering drugs. Am Heart Assoc 8:e010721","journal-title":"Am Heart Assoc"},{"issue":"6285","key":"1593_CR221","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1126\/science.aad3369","volume":"352","author":"A Zhernakova","year":"2016","unstructured":"Zhernakova A et al (2016) Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science 352(6285):565\u2013569","journal-title":"Science"},{"issue":"3","key":"1593_CR222","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.bbrc.2020.04.116","volume":"527","author":"S Zhou","year":"2020","unstructured":"Zhou S et al (2020) Structure of a gut microbial diltiazem-metabolizing enzyme suggests possible substrate binding mode. Biochem Biophys Res Commun 527(3):799\u2013804","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1593_CR223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-021-01184-w","volume":"10","author":"Z Zhou","year":"2022","unstructured":"Zhou Z et al (2022) METABOLIC: high-throughput profiling of microbial genomes for functional traits, metabolism, biogeochemistry, and community-scale functional networks. Microbiome 10(1):1\u201322","journal-title":"Microbiome"},{"issue":"8","key":"1593_CR224","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.3390\/pharmaceutics15082085","volume":"15","author":"R Zhou","year":"2023","unstructured":"Zhou R et al (2023) Effect of gut microbiota on the pharmacokinetics of nifedipine in spontaneously hypertensive rats. Pharmaceutics 15(8):2085","journal-title":"Pharmaceutics"},{"issue":"1","key":"1593_CR225","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1038\/s41467-024-48591-9","volume":"15","author":"M Zhu","year":"2024","unstructured":"Zhu M, Dai X (2024) Shaping of microbial phenotypes by trade-offs. Nat Commun 15(1):4238","journal-title":"Nat Commun"},{"issue":"9","key":"1593_CR226","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/s41419-024-07086-7","volume":"15","author":"L Zhu","year":"2024","unstructured":"Zhu L et al (2024) Epigenetic modification of CD4+ T cells into Tregs by 5-azacytidine as cellular therapeutic for atherosclerosis treatment. Cell Death Dis 15(9):689","journal-title":"Cell Death Dis"},{"issue":"7762","key":"1593_CR227","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-019-1291-3","volume":"570","author":"M Zimmermann","year":"2019","unstructured":"Zimmermann M et al (2019) Mapping human microbiome drug metabolism by gut bacteria and their genes. Nature 570(7762):462\u2013467","journal-title":"Nature"},{"issue":"1","key":"1593_CR228","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.asjsur.2023.08.104","volume":"47","author":"X Zou","year":"2024","unstructured":"Zou X et al (2024) Trimethylamine-N-oxide (TMAO) and predicted risk of cardiovascular events after partial nephrectomy. Asian J Surg 47(1):281\u2013288","journal-title":"Asian J Surg"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01593-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01593-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T04:32:29Z","timestamp":1738729949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01593-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":228,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["1593"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01593-x","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest, financial or otherwise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}